Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Interest Expenses: 2009-2025

Historic Interest Expenses for Cumberland Pharmaceuticals (CPIX) over the last 17 years, with Sep 2025 value amounting to $109,699.

  • Cumberland Pharmaceuticals' Interest Expenses fell 20.15% to $109,699 in Q3 2025 from the same period last year, while for Sep 2025 it was $606,309, marking a year-over-year increase of 8.07%. This contributed to the annual value of $605,508 for FY2024, which is 9.34% down from last year.
  • Cumberland Pharmaceuticals' Interest Expenses amounted to $109,699 in Q3 2025, which was up 0.14% from $109,547 recorded in Q2 2025.
  • In the past 5 years, Cumberland Pharmaceuticals' Interest Expenses registered a high of $223,261 during Q4 2024, and its lowest value of $20,021 during Q3 2021.
  • For the 3-year period, Cumberland Pharmaceuticals' Interest Expenses averaged around $150,583, with its median value being $137,374 (2024).
  • Per our database at Business Quant, Cumberland Pharmaceuticals' Interest Expenses tumbled by 78.35% in 2021 and then surged by 645.92% in 2022.
  • Cumberland Pharmaceuticals' Interest Expenses (Quarterly) stood at $27,734 in 2021, then skyrocketed by 547.06% to $179,456 in 2022, then fell by 0.37% to $178,792 in 2023, then rose by 24.87% to $223,261 in 2024, then declined by 20.15% to $109,699 in 2025.
  • Its Interest Expenses was $109,699 in Q3 2025, compared to $109,547 in Q2 2025 and $163,802 in Q1 2025.